Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

NCT02889692 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: YiQiFang
DRUG: YangYinFang
DRUG: YiQiYangYinFang
DRUG: placebo granules
DRUG: Erlotinib®
DRUG: Gefitinib®
DRUG: Icotinib®

Sponsor

Shanghai University of Traditional Chinese Medicine

Collaborators

[object Object]
[object Object]